BioRestorative Therapies, Inc. (BRTX)
2.14
-0.13
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
2.25
+0.11
(+5.14%)
After-Hours: 20:00
BioRestorative Therapies Profit Margin (Quarterly) : -9.29K% for March 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -9.29K% |
| December 31, 2025 | -16.37K% |
| September 30, 2025 | -25.75K% |
| June 30, 2025 | -875.8% |
| March 31, 2025 | -21.36K% |
| December 31, 2024 | -3.78K% |
| September 30, 2024 | -467.2% |
| June 30, 2024 | -4.52K% |
| March 31, 2024 | -6.35K% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | -8.85K% |
| March 31, 2023 | -22.92K% |
| December 31, 2022 | -117.5K% |
| September 30, 2022 | -16.05K% |
| June 30, 2022 | -6.58K% |
| March 31, 2022 | -30.10K% |
| December 31, 2021 | -408.1K% |
| September 30, 2021 | -52.30K% |
| June 30, 2021 | -27.08K% |
| March 31, 2021 | -86.96K% |
| December 31, 2020 | -33.89K% |
| September 30, 2020 | -5.58K% |
| June 30, 2020 | |
| March 31, 2020 | -29.04K% |
| Date | Value |
|---|---|
| December 31, 2019 | -4.85K% |
| September 30, 2019 | -13.31K% |
| June 30, 2019 | -13.41K% |
| March 31, 2019 | -13.39K% |
| December 31, 2018 | -12.31K% |
| September 30, 2018 | -11.25K% |
| June 30, 2018 | -9.50K% |
| March 31, 2018 | -13.20K% |
| December 31, 2017 | -4.89K% |
| September 30, 2017 | -12.83K% |
| June 30, 2017 | -13.74K% |
| March 31, 2017 | -39.80K% |
| December 31, 2016 | -33.72K% |
| September 30, 2016 | -36.68K% |
| June 30, 2016 | -13.94K% |
| March 31, 2016 | -27.33K% |
| December 31, 2015 | -1.57K% |
| September 30, 2015 | -1.69K% |
| June 30, 2015 | -954.5% |
| March 31, 2015 | -951.9% |
| December 31, 2014 | -1.86K% |
| September 30, 2014 | -688.2% |
| June 30, 2014 | -757.9% |
| March 31, 2014 | -417.4K% |
| December 31, 2013 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -22.65% |
| CareDx, Inc. | 83.85% |
| Natera, Inc. | -8.90% |
| Exagen, Inc. | -16.03% |
| Sera Prognostics, Inc. | -30.46K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -333.4% |
| Return on Assets | -166.5% |
| Return on Invested Capital | -329.9% |
| Gross Profit Margin (Quarterly) | -157.8% |
| Operating Margin (Quarterly) | -14.59K% |
| Return on Net Operating Assets | -1.21K% |